Compare NGVC & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NGVC | AMPH |
|---|---|---|
| Founded | 1955 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 757.8M | 885.4M |
| IPO Year | 2012 | 2005 |
| Metric | NGVC | AMPH |
|---|---|---|
| Price | $31.26 | $19.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $36.00 | $28.38 |
| AVG Volume (30 Days) | 97.2K | ★ 409.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | ★ 36.05 | N/A |
| EPS | ★ 1.07 | 0.14 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $7.08 | $6.90 |
| Revenue Next Year | $6.04 | $4.64 |
| P/E Ratio | ★ $28.05 | $133.71 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.47 | $16.65 |
| 52 Week High | $45.98 | $31.26 |
| Indicator | NGVC | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 49.28 | 46.98 |
| Support Level | $30.36 | $18.92 |
| Resistance Level | $31.94 | $19.99 |
| Average True Range (ATR) | 1.18 | 0.68 |
| MACD | -0.35 | -0.06 |
| Stochastic Oscillator | 45.45 | 37.37 |
Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories: natural and organic food, dietary supplements, natural body care, household, pet care products, books, and handouts. The Company has a single reporting segment, natural and organic retail stores, through which business is conducted. The company generates the majority of its revenue from grocery products and dietary supplements, and the rest from other products.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.